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This study was proposed in search for a new alternative for bone replacement or repair.
Because the systems commonly used in repair of bony defects form bone by going through a
cartilaginous phase, implantation of a piece of cartilage could enhance the healing process by
having a more advanced starting point. However, cartilage has seldom been used to replace
bone due, in part, to the limitations in conventional culture systems that did not allow production
of enough tissue for implants (2). The NASA-developed bioreactors known as STLV (Slow
Turning Lateral Vessel) provide homogeneous distribution of cells, nutrients, and waste
products, with less damaging turbulence and shear forces than conventional systems. Cultures
under these conditions have higher growth rates, viability, and longevity, allowing larger "tissue-
like" aggregates to form, thus opening the possibilities of producing enough tissue for
implantation, along with the inherent advantages of in vitro manipulations (3,4). To assure large
numbers of ceils and to eliminate the use of timed embryos, we proposed to use an immortalized
mouse limb bud cell line as the source of cells.
I. Cell line characterization, propagation, preservation and recovery from freezing.
Cultures using the MPLB-1 (mouse posterior limb bud-l) cell line were set up using T-
flasks to test for cell line propagation, preservation and recovery from freezing. Results were
positive, good cell aggregation and nodule formation was observed. Initial characterization
indicated that differentiating cells formed cartilaginous nodules, as evidenced by histological
staining for sulfated mucosubstances in the cartilage matrix.
Cultures using the MPLB-2 cell line were also set up to run a comparative study with
the MPLB-1 cell line. Results showed that MPLB-2 cells had an initially slower growth rate
than MPLB-1, and that the phenotype is more of fibroblasts than of chondrocytes. Based on
these results from cell line characterization, the MPLB-1 cell line was chosen to be used for
growth inside the bioreactor to produce cartilaginous aggregates for implantation.
II. Growth of MPLB-1 cell line inside a bioreactor.
MPLB-1 cells were cultured inside a bioreactor with a culture vessel capacity of 110ml
(Synthecon, Inc). To increase cell proliferation and reduce differentiation in the system in order
to allow growth of larger aggregates, some cultures were grown without ascorbic acid. Cells
were also cultured either with or without aggregation prior to injection to the rotating vessel; and
with or without attachment to cylindrical agar molds (7mm L, 4ram dia.). Control cultures were
maintained in T-flasks. The superior growth of cells within the bioreactor was immediately
apparent. Results also showed that cells used in this application did not have to be aggregated
or provided with a substrate prior to putting them in the system. After only 3 days of culture
it was clear that the cells were proliferating faster in suspension than when attached to the agar
templates. Aggregates were cultured for 107 days. The cells growing in suspension formed
large size aggregates that were used for implantation at selected times, but the cells grown
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attachedto theagartemplatesdid notproliferateasrapidlyanddid not form aggregatesuitable
for implantation.
Imageanalysesof nodulesize,asindicatedby area,perimeter,minimumandmaximum
diameter,anddensityshowedthat aggregatesincreasedin size throughoutthe more than three
month culture period. The meanareaof aggregateswithin the culture increasedduring the
courseof thefirst two months. At theendof thethird month, theareaof the largestaggregate
measuredwas 20mm2 and the smallest .01mm 2. There is continued formation of small
aggregates from single cells that proliferate and form new growing groups of cells.
Aggregate staining with Alcian blue (pH= 1) indicated the presence of cartilaginous
matrix, but light microscopy of the aggregates grown without ascorbic acid showed cells with
appearance of pre-chondrocytes with very little metachromasia. Thus, this was the basal
condition of the aggregates grown without ascorbic acid upon implantation: not very well
differentiated, although some cartilage matrix (metachromatic matrix) was present and sometimes
even a perichondrium formed around the aggregates. With the addition of ascorbic acid, the
basal condition of the aggregates upon implantation was slightly more differentiated, had more
cartilage matrix, but had little hypertrophy still. This confirmed our predictions of being able
to manipulate the cartilage phenotype through changing the medium components. However, the
amount of hypertrophy observed in the aggregates, as well as the amount of matrix produced
was not comparable to that obtained from primary cultures.
HI. Aggregates implanted subcutaneously in mice.
Cartilaginous aggregates grown inside the bioreactor were implanted, subcutaneously, in
the costal region of eight-week old, C3H male mice (I-Iarlan Sprague Dawley). Appropriate
animal care, consistent with the Animal Welfare Act and NIH Policy and Guide were provided
throughout this experiment. Two weeks prior to implantation, mice underwent surgery to insert
a glass disc in each costal region, in order to induce formation of a non-inflamed vascular
connective tissue in the site of future implantation. At time of aggregate implantation, disks
were removed and aggregates were implanted. Three groups of mice received implants of
aggregates grown without ascorbic acid: 1) Aggregates grown for 41 days were implanted for
1-5 weeks. 2) Aggregates grown for 62 days were implanted for 1-9 weeks. 3) Aggregates
grown for 84 days were implanted for 1-12 weeks. Aggregates grown with ascorbic acid for
24 and 32 days were implanted for 2d, or 3-5 weeks.
Aggregates grown inside the bioreactor and implanted for at least 3 weeks showed good
vascularization. Hypertrophy, however, was limited even in those aggregates implanted at more
advanced stages of differentiation. Results in the in vivo implant system do not seem to be as
clearcut as when primary limbbud cells rather than a cell line was used. In some cases, the cells
within the implants appear to have been multipotent, and yielded muscle as well as cartilage-like
tissue. This result may be due to the lack of hypertrophy reached in the initial nodules that were
implanted, as previous studies with primary cultures indicated that formation of bone might be
dependent on the initial stage of differentiation of the implant.
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IV. Fulfillment of specific aims.
Specific aims have been fulfilled as follows:
Aim 1. To assess the ability of MPLB2 (Mouse Posterior Limb Bud-2), a mouse limb bud
cell line, to produce healthy cartilaginous aggregates of a particular size and shape when
cultured in the commercially available STLV known as a RCCS (Rotary Cylindrical Culture
System; Synthecon, Inc.). The MPLB-1 cell line produced large numbers of cells, which
differentiated well in T-flasks, forming numerous Alcian-blue positive nodules. Growth in the
bioreactor was also phenomenal, but little differentiation of cartilage in the aggregates in the
bioreactors occurred.
Aim 2. To identify the stage and amount of cartilage within the aggregates prior to
implantation, through assessment of the quality (normality) of the cartilaginous aggregates
produced. MPLB-1 cell aggregates grown inside the bioreactor were large cartilaginous nodules,
as assessed by cartilage specific Alcian blue staining. However, the stage of differentiation
showed little hypertrophy and reduced amount of matrix. This results are similar to those
previously observed in microgravity, in vivo and in vitro.
Aim 3. To quantitate the amount of bone produced by the implant in an in vivo implant
system. Implanted nodules appeared to have vascularized, but cells within nodules were
apparently multipotent and produced other tissue besides cartilage on implantation. These results
have led us to return to our original system of culturing cells from mouse limb buds, in spite
of the difficulty of having to use large number of timed pregnant mice.
V. Presentations/publications. (*Attachments.)
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Lecture on "The Use of Engineered Cartilage to Repair Bony Defects" for a graduate
course in Biomaterials at the UT Dental Branch, Oct. 23.
Two presentations, with an abstract and one paper published in the proceedings of In
Space '96 conference, Tokyo, Japan, Nov. 11-12, organized by the Japan Space
Promotion Center (JSUP). Presented results of previous studies and current research,
as well as potential uses of the bioreactor on Space Station. "The Differentiation of
Chondrocytes in Altered Gravity" and "New Views, New Vistas in the Life Sciences:
ISS and Beyond".
Presentation at the 15th Annual Houston Conference on Biomedical Engineering
Research. Abstract.
Presentation at the 13th Annual Meeting of the American Society for Gravitational and
Space Biology (ASGSB), Washington, DC, November 19-22, 1997.
Presentation at the Third Annual UT-Houston Research Day, Edwin Hornberger
Conference Center, October 3, 1997.
Presentation at the Second Conference on Recent Advances in Fermentation Technology
(RAFT II), "Microgravity Fermentations" session, San Diego, California, November 15-
18, 1997. Abstract.
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NASA°s interest in tissue engineering derived from the idea that it might be possible in space to
grow tissues, for example, articular cartilage to cover a bone's surface, without distortion of the growing
tissue by gravity. In implementing its tissue engineering studies, which fall under the biotechnoiogy
program of the Mierogravity Science and Application Division, NASA has concentrated on development
ofa bioreactor which can be used at lg, or in space, to grow three-dimensional tissues which are more
representative of in vivo tissue construction. Tissues grown to date include articular cartilage and bone,
as well as cocultivation of cancer cells and normal cells. Temporary cartilage (or endochondral cartilage),
that is, cartilage that is replaced by bone, has also been cultivated because a serious problem facing the
orthopedic or oral surgeon today is the procurement of materials to provide support and induce bone
during repair ofbony defects I. This problem is complicated by the loss of traditional cadaver sources of
bone due to potential infection with FIIV. Because many bones form by endochondral ossification, that
is, by bone repla_ of a cartilage model, which is also the process by which fractures heal, cartilage
can be used to repair bone, but its use has been limited in part by the amount of tissue available from
conventional tissue culture systems. Embryonic limb cells cultured in a Rotating Wall Vessel produce
cartilageand thecartilaginousaggregatesgrown in thissystem can be implanted subcutaneously, where
they hypertrophy, calcify, vascularize, and recruit additional cells. But on earth, gravity limits the size
of aggregates that can be grown in this system. Therefore, we plan to use microgravity to engineer
cartilaginous tissue that can be used in repair of bony defects. By using the Rotating Wall Perfused
Vessel (RWPV) tissue culture system developed by NASA coupled with the microgravity environment
we plan to grow pieces of cartilage tissue of a size that has not been possible on earth, a problem that
has limited the use of cartilage in bone repair, despite its irmnunogenic privilege. To assure large numbers i
of cells and to eliminate the use of timed embryos, we propose to. use an immortalized cell line as a
source of cells, the MPLBI cell line derived from embryonic mouse limb bud.
Supported by TMC/NASA Subcontract NCC9-36.
Journal of Cellular Biochemistry 51 (3), 1993.
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A problem facing the oral surgeon today is the procurement of materials
to provide support and induce bone during repair of bony defects.
Because many bones form by endochondral ossification, cartilage can
be used to repair bone, but its use has been limited in part by the
amount of tissue available from conventional tissue culture systems.
The rotating wall systems developed by NASA provide homogeneous
distribution of cells, nutrients, and waste products; conditions that
promote higher growth rates, viability, and longevity that allow larger
3-D "tissue-like" aggregates to form. Using these vessels, we have
grown cartilage aggregates that when implanted subcutaneously begin
the ossification process. But on earth, the size of aggregates we can
produce in this system is still limited by the presence of gravity which
results in a constant need to increase the RPMs to maintain aggregates
in suspension. The sedimentation effects can not be overcome without
excessive rotation, thus subjecting cells to considerable forces. In space
however, rotation is not required to keep aggregates in suspension, and
their size will not be limited by sedimentation. The microgravity
environment will allow us to grow pieces of cartilage tissue of a size
that has not been possible on earth, large enough to be useful in bone
repair. --Supported by TMC/NASA Subcontract NCC9-36.
